APA (7th ed.) Citation

Alderman, M. H., Davis, B. R., Piller, L. B., Ford, C. E., Baraniuk, M. S., Pressel, S. L., . . . Group, A. C. R. (2016). Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]). American Journal of Cardiology, 117(1), 105. https://doi.org/10.1016/j.amjcard.2015.10.012

Chicago Style (17th ed.) Citation

Alderman, Michael H., et al. "Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])." American Journal of Cardiology 117, no. 1 (2016): 105. https://doi.org/10.1016/j.amjcard.2015.10.012.

MLA (9th ed.) Citation

Alderman, Michael H., et al. "Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])." American Journal of Cardiology, vol. 117, no. 1, 2016, p. 105, https://doi.org/10.1016/j.amjcard.2015.10.012.